Browse by Phase
Phase 1 Clinical Trials
Phase 1 trials test a new drug or treatment in a small group (20–80 people) for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects.
Total Trials
604
Recruiting Now
604
Top Conditions in Phase 1
NCT07377045 Phase 1
Recruiting
Clinical Trial of OMTX705 in Combination With Gemcitabine/Nab-Paclitaxel and Tis...
Condition
Pancreatic Adenocarcinoma Metastatic
Enrollment
69 pts
Location
United States, Spain
Sponsor
Oncomatryx Biopharma S.L.
NCT06115902 Phase 1
Recruiting
A Study of TQB2102 for Injection in Patients With Recurrent/Metastatic Breast Ca...
Condition
Breast Cancer
Enrollment
150 pts
Location
China
Sponsor
Chia Tai Tianqing Pharmaceutic
NCT07184502 Phase 1
Recruiting
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ZT003 Inject...
Condition
Healthy
Enrollment
76 pts
Location
Australia
Sponsor
Beijing QL Biopharmaceutical C
NCT04196257 Phase 1
Recruiting
BP1001-A in Patients With Advanced or Recurrent Solid Tumors
Condition
Solid Tumor, Adult
Enrollment
50 pts
Location
United States
Sponsor
Bio-Path Holdings, Inc.
NCT06880081 Phase 1
Recruiting
Study of PN20 in Adult Patients With Primary Immune Thrombocytopenia (ITP)
Condition
Primary Immune Thrombocytopenia (ITP)
Enrollment
12 pts
Location
China
Sponsor
Chongqing Peg-Bio Biopharm Co.
NCT06907628 Phase 1
Recruiting
A Trial of SHR-3792 Injection in Patients With Advanced Solid Tumors
Condition
Advanced Solid Tumors
Enrollment
150 pts
Location
China
Sponsor
Suzhou Suncadia Biopharmaceuti
NCT06639724 Phase 1
Recruiting
Perioperative Fostamatinib With Gemcitabine and Nab-paclitaxel in Resectable Pan...
Condition
Pancreatic Ductal Adenocarcinoma (PDAC)
Enrollment
36 pts
Location
United States
Sponsor
University of California, San
NCT06533059 Phase 1
Recruiting
A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant S...
Condition
Cancer
Enrollment
110 pts
Location
United States, Australia, France
Sponsor
Alterome Therapeutics, Inc.
NCT07269080 Phase 1
Recruiting
STM-06: POLARIS-POlymetastic Lesion Ablative Radiotherapy With Immunotherapy Stu...
Condition
Advanced Solid Tumor
Enrollment
28 pts
Location
United States
Sponsor
University of Illinois at Chic
NCT05605119 Phase 1
Recruiting
First in Human, Dose Escalation, Dose Expansion Study of AUR105
Condition
Solid Tumor, Adult
Enrollment
40 pts
Location
India
Sponsor
Aurigene Discovery Technologie
NCT05154253 Phase 1
Recruiting
Augmenting Ankle Plantarflexor Function in Cerebral Palsy
Condition
Cerebral Palsy
Enrollment
36 pts
Location
United States
Sponsor
Northern Arizona University
NCT07361029 Phase 1
Recruiting
CD19 Chimeric Antigen Receptor (CAR) T Cells in Adults With Relapsed/Refractory ...
Condition
Relapsed Refractory Acute Lymphoblastic Leukemia
Enrollment
24 pts
Location
Saudi Arabia
Sponsor
King Faisal Specialist Hospita
NCT06429930 Phase 1
Recruiting
Safety, Tolerability and Pharmacokinetics Study of L608 in Healthy Adults
Condition
Pulmonary Arterial Hypertension
Enrollment
32 pts
Location
New Zealand
Sponsor
Pharmosa Biopharm Inc.
NCT06789107 Phase 1
Recruiting
Blinatumomab in Refractory Active Childhood Systemic Lupus Erythematosus
Condition
Systemic Lupus Erythematosus (SLE)
Enrollment
6 pts
Location
China
Sponsor
Mao Jianhua
NCT06914037 Phase 1
Recruiting
A Clinical Study of CHT101 in CD70-Positive Relapsed or Refractory Hematological...
Condition
Peripheral T-cell Lymphoma
Enrollment
24 pts
Location
China
Sponsor
Tianjin Medical University Can
NCT05900895 Phase 1
Recruiting
Estradiol Plus Olaparib for Breast Cancer (PHOEBE)
Condition
Metastatic Breast Cancer
Enrollment
6 pts
Location
United States
Sponsor
Mary D Chamberlin
NCT06681181 Phase 1
Recruiting
A First-time in Human (FTIH) Study to Evaluate Safety, Tolerability, Pharmacokin...
Condition
Colitis, Ulcerative
Enrollment
48 pts
Location
United Kingdom
Sponsor
GlaxoSmithKline
NCT07204925 Phase 1
Recruiting
Towards Efficient Personalization of Computerized Lower Limb Prostheses Via Rein...
Condition
Transfemoral Amputation
Enrollment
24 pts
Location
United States
Sponsor
North Carolina State Universit
NCT07148089 Phase 1
Recruiting
A Study of SGT-501 Gene Therapy in Catecholaminergic Polymorphic Ventricular Tac...
Condition
Catecholaminergic Polymorphic Ventricular Tachycardia
Enrollment
18 pts
Location
United States, Canada
Sponsor
Solid Biosciences Inc.
NCT05200650 Phase 1
Recruiting
A Single Arm, Prospective, Open Label, Multi Center, Phase Ib Study to Evaluate ...
Condition
Head and Neck Cancer
Enrollment
20 pts
Location
Israel
Sponsor
IntraGel Therapeutics
NCT06163391 Phase 1
Recruiting
A Study to Assess Safety and Efficacy of SOT201 in Patients With Advanced/Metast...
Condition
Advanced Solid Tumor
Enrollment
40 pts
Location
United States, Belgium, Czechia
Sponsor
SOTIO Biotech AG
NCT04739813 Phase 1
Recruiting
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid in Combination Wit...
Condition
Lymphoma
Enrollment
55 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT07284186 Phase 1
Recruiting
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
Condition
Esophageal Squamous Cell Carcinoma
Enrollment
155 pts
Location
United States
Sponsor
Plexium, Inc.
NCT05656573 Phase 1
Recruiting
CART-PSMA Cells for Advanced Prostate Cancer
Condition
Prostate Cancer
Enrollment
20 pts
Location
China
Sponsor
Nova Therapeutics LLC
NCT06760117 Phase 1
Recruiting
UGT1A1 Genotype-drien Phase I Study of Irinotecan in VIT Regimen for the Treatme...
Condition
Pediatric Solid Tumor
Enrollment
39 pts
Location
China
Sponsor
Sun Yat-sen University